OncoMatch/Clinical Trials/Breast Cancer
Breast Cancer Clinical Trials
OncoMatch filters Breast Cancer trials by the molecular markers that determine eligibility — ERBB2, ESR1, PGR, BRCA1, and more. Enter your biomarker results to see only the trials you may qualify for.
Compare eligibility criteriaBiomarkers tested in Breast Cancer trials
These are the molecular markers most commonly required or evaluated in Breast Cancer eligibility criteria. OncoMatch extracts them from each trial's protocol and matches them against your test results.
Top recruiting Breast Cancer trials
Ranked by phase and number of US sites. See all trials matched to your profile →
E-Mindfulness Approaches for Living After Breast Cancer
NRG Oncology
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Gilead Sciences
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Novartis Pharmaceuticals
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Greenwich LifeSciences, Inc.
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
BioNTech SE
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
Memorial Sloan Kettering Cancer Center
How OncoMatch finds Breast Cancer trials for you
AI reads the protocol
Every Breast Cancer trial on ClinicalTrials.gov has eligibility criteria written for regulators. OncoMatch uses large language models to extract the structured requirements — biomarkers, stage, prior therapy, and more — from that text.
You enter your results
Select Breast Cancer and mark your biomarker results — ERBB2, ESR1, PGR — as positive, negative, or not tested. Your data never leaves your device.
See only relevant trials
Results filter instantly. Each trial shows exactly which criteria you meet, which you don't, and which need more information. Bring the list to your oncologist.